Who's leading Australia's drug charge?
With 10 prescription medicine applications on the TGA's review list, this pharma is at the forefront of bringing new therapies to Australia
With 10 prescription medicine applications on the TGA's review list, this pharma is at the forefront of bringing new therapies to Australia
Who's nabbed the former Health Minister as a Non-Executive Director to advise on medicines policy and support the company's next phase of growth?
With this company ready to accelerate growth, a successful entrepreneur known across industry takes on Chair role after an oversubscribed seed funding round
The Aussie giant said it stands behind the science of the new technology but changes to the regulatory regime in the US has made the broader market less attractive
Strong growth for some drugs, sharp falls and lost exclusivity for others means the Top 10 PBS Earners list now looks very different than it did a year ago
An expanded PBS listing has been leapt upon by HCPs and patients, seeing reimbursements skyrocket
New report lifts the lid on what rival sales reps are telling HCPs to differentiate their competing blockbuster products
New Aussie biotech Managing Director and CEO named as predecessor readies to pursue a new opportunity overseas
This Aussie team is on a mid-year break to reset and recharge with a company-wide shutdown guaranteeing there will be no work interruptions and no overflowing inbox next Monday
Health Minister says this “revolutionary class of drugs” must be subsidised but price negotiations have hit a wall
Aussie leader unveils his next career move after departing a top US-based role at J&J a fortnight ago
There has been a seismic shift in Country Leadership in Australia with 21 ANZ bosses departing in just 12 months
A meteoric rise to the top for this former MD who has gone from Franchise Head to Country Head in just 10 months